Effectiveness of gefitinib (Iressa) as first-line therapy for inoperable non-small-cell lung cancer with mutated EGFR gene (phase II study) (Q43111144)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effectiveness of gefitinib (Iressa) as first-line therapy for inoperable non-small-cell lung cancer with mutated EGFR gene (phase II study) |
scientific article published in January 2010 |
Statements
1 reference
Effectiveness of gefitinib (Iressa) as first-line therapy for inoperable non-small-cell lung cancer with mutated EGFR gene (phase II study) (English)
1 reference
V M Moiseenko
1 reference
S A Protsenko
1 reference
I I Semenov
1 reference
F V Moiseenko
1 reference
E V Levchenko
1 reference
A S Barchuk
1 reference
D E Matsko
1 reference
A O Ivantsov
1 reference
A G Ievleva
1 reference
N V Mitiushkina
1 reference
A V Togo
1 reference
E N Imianitov
1 reference
1 January 2010
1 reference
1 reference
56
1 reference
1
1 reference
20-23
1 reference
Identifiers
1 reference